Old sunscreens linked to higher melanoma odds far from the equator

Sunscreen is the default advice for skin cancer prevention, yet whether it prevents melanoma specifically has long been uncertain. The concern the authors explore is subtle: common formulations over the study period absorbed UVB, the wavelengths that cause sunburn, while transmitting large quantities of UVA. By preventing the burning that would otherwise drive people indoors, such products could in principle allow fair-skinned users to absorb far more UVA than they otherwise would. Whether that translates into measurable melanoma risk, and whether the answer differs by how far from the equator people live, is the question this analysis set out to test.

The authors searched PubMed for all known studies of the association between sunscreen use and melanoma risk published between 1966 and 2007. Eighteen studies were identified, of which 17 met the criteria for inclusion in the analysis. Ten had been conducted at latitudes greater than 40 degrees from the equator and 7 at 40 degrees or closer. Data were pooled for all latitudes combined and then separately within the two latitude bands, and the relationship of skin pigmentation and latitude with the odds ratios was estimated using linear regression.

Across all latitudes combined, sunscreen use showed no statistically significant association with melanoma, with an odds ratio of 1.2 whose range included the possibility of no effect. The picture split sharply by geography. At latitudes above 40 degrees from the equator, sunscreen use was associated with 1.6 times the odds of melanoma. At 40 degrees or below, the direction reversed, with an odds ratio of 0.7 suggesting lower odds among sunscreen users. In both strata the underlying studies disagreed with each other substantially, a limitation the authors flag throughout the analysis.

The authors' interpretation is that formulations absorbing UVB almost completely while transmitting large quantities of UVA may contribute to melanoma risk in populations at higher latitudes. The finding complicated rather than overturned sun-safety advice: these are pooled comparisons from studies that followed people rather than assigning sunscreen at random, so users may simply have had different sun exposure or different skin. The latitude split is a pattern in need of explanation, and because the search window closed in 2007, the analysis says nothing about formulations that came afterwards. How much UVA protection matters for melanoma specifically was left open.

This is not a reason to abandon sunscreen; it is a reason to understand what the product in your bag actually blocks. The signal here attaches to older UVB-focused formulations used in high-latitude populations, and to the behaviour such products may enable: staying in the sun longer because you are not burning. Since the data cannot separate the sunscreen from the sun habits of the people who used it, the honest reading is that sunburn protection and melanoma protection were not the same thing across these decades. What a formula transmits can matter as much as what it absorbs.